INCY – Incyte Corporation – Fundamental analysis, financial statements, key ratios, and fair value analysis

Incyte Corporation

Healthcare
Biotechnology
72.27
4.21
6.19%
100.81
58.5
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)-0.52
EPS Estimate Currrent Qtr0.31
Book Value Per Share8.47
Market Cap 15 Billion
PE Ratio NA
Dividend YieldNA

Stock Yield

Stock Return 7 Days6.46%
Stock Return 15 Days-3.92%
Stock Return 30 Days -8.84%
Stock Return 3 Months-10.84%
Stock Return One Year-38.27%
Stock Return 3 Years-36.97%

Stock Technical Analysis

Relative Strengh Index (14)51.03
Average True Range (14)3.12
Momentum (14)0.39
Simple Moving Average (14) 0.39
Time Series Forecast (14)59.97
Time Series Forecast (30) 65.74

Stock News

Financial Statements

index2014201520162017
Revenue511 Million754 Million1 Billion2 Billion
Cost of Revenue3 Million27 Million58 Million79 Million
Gross Profit508 Million727 Million1 Billion1 Billion
Gross Margin (%)99.41%96.42%94.74%94.83%
Selling General and Administrative Expense166 Million197 Million303 Million366 Million
Other operating expenses344 Million477 Million598 Million1 Billion
Earning Before Interest and Taxes EBIT-2 Million53 Million146 Million-305 Million
EBIT/Operating Margin (%)-0.00%7.05%13.22%-0.00%
Interest Expense47 Million46 Million39 Million7 Million
Other non-operating expenses/income0000
Earnings before Tax-49 Million8 Million107 Million-312 Million
Income Tax Expense-66 Thousand1 Million3 Million852 Thousand
Net Income-48 Million7 Million104 Million-313 Million
Net Margin (%)-0.00%0.87%9.43%-0.00%
Earnings per share from operating income-0271.3162.59683-1
Earnings per Diluted Share-00.030.54-2
Dividends per Basic Common Share0000
Weighted average number of shares outstanding167 Million218 Million193 Million205 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue444 Million382 Million522 Million450 Million
Cost of Revenue22 Million18 Million25 Million25 Million
Gross Profit422 Million364 Million497 Million425 Million
Gross Margin (%)94.97%95.26%95.23%94.49%
Selling General and Administrative Expense98 Million121 Million108 Million97 Million
Other operating expenses472 Million283 Million334 Million297 Million
Earning Before Interest and Taxes EBIT-148 Million-40 Million54 Million31 Million
EBIT/Operating Margin (%)-0.00%-0.00%10.43%6.98%
Interest Expense373 Thousand385 Thousand398 Thousand405 Thousand
Other non-operating expenses/income0000
Earnings before Tax-148 Million-40 Million54 Million31 Million
Income Tax Expense1 Million786 Thousand2 Million2 Million
Net Income-150 Million-41 Million52 Million29 Million
Net Margin (%)-0.00%-0.00%10.05%6.49%
Earnings per share from operating income-1-54.326677.68268
Earnings per Diluted Share-1-00.240.14
Dividends per Basic Common Share0000
Weighted average number of shares outstanding208 Million217 Million218 Million208 Million
index2014201520162017
Cash and Equivalents467 Million536 Million653 Million900 Million
Trade and Non Trade Receivables58 Million114 Million149 Million266 Million
Inventory19 Million19 Million19 Million14 Million
Other current assets1 Billion1 Billion1 Billion2 Billion
Current Assets680 Million842 Million994 Million2 Billion
Total Non-Current Assets117 Million165 Million644 Million798 Million
Total Assets796 Million1 Billion2 Billion2 Billion
Trade and Non Trade Payables24 Million30 Million76 Million68 Million
Other current liabilities197 Million138 Million198 Million308 Million
Current Liabilities221 Million168 Million274 Million375 Million
Liabilities Non Current657 Million668 Million946 Million297 Million
Accumulated Retained Earnings Deficit-2 Billion-2 Billion-2 Billion-2 Billion
Shareholder’s equity other2 Billion2 Billion2 Billion4 Billion
Shareholders Equity-82 Million171 Million419 Million2 Billion
Noncontrolling interests442 Million336 Million547 Million751 Million
Total Assets796 Million1 Billion2 Billion2 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents900 Million895 Million930 Million1 Billion
Trade and Non Trade Receivables266 Million220 Million316 Million248 Million
Inventory14 Million13 Million13 Million11 Million
Other current assets2 Billion2 Billion2 Billion3 Billion
Current Assets2 Billion1 Billion2 Billion2 Billion
Total Non-Current Assets798 Million836 Million799 Million820 Million
Total Assets2 Billion2 Billion2 Billion3 Billion
Trade and Non Trade Payables68 Million74 Million76 Million95 Million
Other current liabilities308 Million307 Million293 Million327 Million
Current Liabilities375 Million381 Million368 Million422 Million
Liabilities Non Current297 Million297 Million296 Million295 Million
Accumulated Retained Earnings Deficit-2 Billion-2 Billion-2 Billion-2 Billion
Shareholder’s equity other4 Billion4 Billion4 Billion4 Billion
Shareholders Equity2 Billion2 Billion2 Billion2 Billion
Noncontrolling interests751 Million762 Million736 Million845 Million
Total Assets2 Billion2 Billion2 Billion3 Billion
index2014201520162017
Net Cash Flow from Operations26 Million89 Million305 Million-93 Million
Capital Expenditure-28 Million-26 Million-120 Million-111 Million
Net Cash Flow from Investing-138 Million-105 Million-232 Million-350 Million
Net Cash Flow from Financing93 Million85 Million59 Million690 Million
Cash and Equivalents467 Million536 Million653 Million900 Million
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations-89 Million21 Million32 Million199 Million
Capital Expenditure-25 Million-13 Million-11 Million-25 Million
Net Cash Flow from Investing-143 Million-29 Million-4 Million-18 Million
Net Cash Flow from Financing4 Million3 Million6 Million2 Million
Cash and Equivalents900 Million895 Million930 Million1 Billion

Stock Price History

table